NUMB and glioblastoma: ZIKV’s oncolytic properties against GBM involve multiple mechanisms: strong tropism for neural progenitor cells, induction of apoptosis via Caspase-3 activation [15], inhibition of glioma stem cell tumorigenicity by NS5 [4], and modulation of cellular signaling proteins such as NOTCH and NUMB [7].